Actively Recruiting
BE.Amycon Biobank & Data Registry UZ Leuven
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-02-27
505
Participants Needed
2
Research Sites
222 weeks
Total Duration
On this page
Sponsors
U
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
F
Flemish institute of biotechnology (VIB)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".
CONDITIONS
Official Title
BE.Amycon Biobank & Data Registry UZ Leuven
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide consent and sign informed consent form
- Be 18 years or older
- Have a diagnosis of amyloidosis (suspected or confirmed, any subtype)
- For sample collection: newly diagnosed amyloidosis or relapse of AL amyloidosis
You will not qualify if you...
- Not willing to sign informed consent
- Not able to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UZ Leuven Gasthuisberg - hematology
Leuven, Belgium, 3000
Actively Recruiting
2
UZ Leuven Gasthuisberg - cardiology
Leuven, Belgium
Actively Recruiting
Research Team
M
Michel Delforge
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here